Si-Bone yesterday registered for an initial public offering, looking to bring in approximately $97.8 million, according to an SEC filing.
The Santa Clara, Calif.-based company said that it plans to list on the Nasdaq Global Market under the ticker symbol “SIBN.”
Morgan Stanley and BofA Merrill Lynch are acting as joint book-running managers for the IPO, with Cannaccord Genuity and JMP Securities acting as co-managers, according to a press release.
The company has not yet stated how many shares it plans to list in the offering, but said that it expects to pay $12,170 in registration fees for the offering, according to an SEC filing.
Last month, Si-Bone said that France added the iFuse implant system to its List of Refundable Products and services, clearing it for reimbursement by the French National Healthcare System.
DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.
Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry.
Use code LASTCHANCE to save an additional 20%.